Spotlight on Life Sciences
Supply Chain Outlook
As the world continues to experience new disease, illness and public health emergencies, innovation around drugs and treatments will continue in the life sciences industry.
With that industry growth will come more challenges. Life science leaders will increasingly need to address and mitigate supply chain disruptions to meet demand for advances in immunotherapy, genomic medicine, biotechnology, and more.
Download this spotlight on life sciences supply chain outlook report and understand how greater supply chain resilience may increase capacity, and accelerate drug discovery and therapeutics.
Key Insights:
- Exclusive life sciences disruption data and industry analysis
- Market drivers and risk trends, including financial risks, regulations and skilled labor shortages
- Drug shortage and biomanufacturing outlook
- What constitutes a resilient global life sciences supply chain?
- Building life science resiliency with the patient experience in mind